See analyst estimates and all valuation multiples for Chemicals
Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
---|---|---|---|
$236B | 7.1x | 18.0x | |
$97.8B | 4.2x | 21.3x | |
$83.5B | 5.2x | 22.4x | |
$80.2B | 6.7x | 15.9x | |
$69.6B | 0.9x | 7.7x | |
$52.1B | 25.0x | 1391.6x | |
$48.0B | 2.7x | 7.0x | |
$47.4B | 3.2x | 16.5x | |
$44.4B | 1.2x | 8.5x | |
$42.7B | 1.6x | 7.5x | |
$37.7B | 1.4x | 8.3x | |
$36.6B | 0.9x | 8.1x | |
$36.6B | 2.9x | 11.3x | |
$34.8B | 7.3x | 19.7x | |
$32.3B | 2.0x | 11.3x | |
$32.1B | 1.0x | 8.7x | |
$31.1B | 0.9x | 8.5x | |
$31.0B | 0.9x | 6.6x | |
$30.3B | 2.0x | 11.5x | |
$28.5B | 2.6x | 13.3x | |
$26.6B | 6.6x | 36.8x | |
$26.5B | 2.2x | 13.2x | |
$23.7B | 4.1x | 10.2x | |
$21.0B | 2.3x | 10.2x | |
$20.3B | 3.4x | 10.1x | |
$19.4B | 4.4x | 16.2x | |
$18.6B | 0.5x | 2.3x | |
$18.6B | 1.9x | 8.6x | |
$18.1B | 7.1x | 24.1x | |
$17.4B | 3.3x | 12.1x | |
$16.9B | 2.8x | 13.6x | |
$16.8B | 1.3x | 9.6x | |
$16.8B | 2.7x | 6.9x | |
$16.5B | 2.2x | 14.3x | |
$16.5B | 1.0x | 13.8x | |
$14.0B | 3.1x | 9.3x | |
$13.8B | 1.2x | 7.4x | |
$13.6B | 1.5x | 7.8x | |
$13.6B | 0.9x | 5.6x | |
$13.4B | 0.8x | 5.6x | |
$13.3B | 2.6x | 13.1x | |
$11.8B | 3.8x | 10.4x | |
$11.0B | 4.9x | 11.8x | |
$10.8B | 1.6x | 6.3x | |
$9.9B | 1.3x | 6.2x | |
$9.4B | 0.5x | 5.6x | |
$9.2B | 1.6x | 13.4x | |
$9.0B | 2.1x | 10.0x | |
$8.8B | 0.8x | 5.1x | |
$8.2B | 0.6x | 3.1x | |
$6.9B | 7.2x | 26.9x | |
$6.6B | 3.0x | 8.9x | |
$6.6B | 2.4x | 272.0x | |
$6.3B | 1.5x | 10.1x | |
$5.9B | 1.2x | 9.8x | |
$5.6B | 1.0x | 4.7x | |
$5.5B | 2.8x | 11.0x | |
$5.5B | n/a | n/a | |
$5.4B | 0.7x | 7.8x | |
$5.4B | 1.0x | 6.3x | |
$5.4B | 0.6x | 6.8x | |
$5.4B | 6.6x | 23.0x | |
$4.8B | 0.7x | 5.7x | |
$4.8B | 1.9x | 14.0x | |
$4.5B | 0.4x | 12.7x | |
$4.3B | n/a | n/a | |
$3.7B | 1.7x | 8.4x | |
$3.6B | 1.1x | 5.5x | |
$3.6B | 0.9x | 15.5x | |
$3.5B | n/a | n/a | |
$3.4B | 12.3x | 53.4x | |
$3.0B | 5.0x | 27.3x | |
$2.8B | 0.9x | -157.6x | |
$2.5B | 0.8x | 7.0x | |
$2.4B | 0.6x | 3.4x | |
$2.4B | n/a | n/a | |
$2.2B | 2.8x | 11.1x | |
$2.1B | 0.7x | 6.3x | |
$2.0B | 2.1x | 10.9x | |
$1.9B | 7.4x | 22.7x | |
$1.8B | 2.7x | 14.2x | |
$1.8B | 0.2x | 5.1x | |
$1.8B | 1.5x | 11.4x | |
$1.6B | 1.5x | 8.7x | |
$1.5B | 2.2x | 9.3x | |
$1.4B | n/a | n/a | |
$1.4B | 2.6x | n/a | |
$1.2B | 1.2x | 11.8x | |
$1.1B | 0.6x | 21.1x | |
$947M | 0.6x | 6.7x | |
$939M | 2.2x | 32.3x | |
$805M | n/a | n/a | |
$716M | n/a | n/a | |
$638M | 0.5x | 3.9x | |
$632M | 1.1x | 7.5x | |
$592M | n/a | n/a | |
$586M | 1.2x | 6.0x | |
$558M | 0.2x | 28.3x | |
$558M | 0.4x | 6.0x | |
$498M | 0.9x | 5.6x | |
$468M | 4.3x | -20.5x | |
$462M | 8.8x | 28.8x | |
$460M | 1.2x | 8.8x | |
$428M | 0.6x | 5.6x | |
$416M | 0.8x | 2.7x | |
$406M | 0.7x | 5.4x | |
$401M | 1.7x | 10.1x | |
$359M | n/a | n/a | |
$350M | 0.2x | 3.2x | |
$348M | 1.5x | 8.3x | |
$297M | 7.1x | -7.4x | |
$280M | n/a | n/a | |
$275M | 0.5x | 6.9x | |
$263M | n/a | n/a | |
$251M | n/a | n/a | |
$222M | n/a | n/a | |
$200M | n/a | n/a | |
$198M | 9.0x | -7.5x | |
$175M | 7689.4x | -555.3x | |
$171M | 0.4x | 4.3x | |
$150M | 0.6x | 3.8x | |
$149M | n/a | n/a | |
$140M | 1.2x | 6.4x | |
$129M | 6.1x | 18.5x | |
$119M | 5.9x | -5.8x | |
$106M | n/a | n/a | |
$99.1M | n/a | n/a | |
$80.0M | 0.8x | 4.3x | |
$79.1M | n/a | n/a | |
$75.9M | 0.6x | 8.6x | |
$75.9M | 23.4x | -2.2x | |
$75.4M | 335.6x | -12.1x | |
$70.2M | n/a | n/a | |
$64.4M | n/a | n/a | |
$47.5M | 0.5x | 4.5x | |
$46.2M | 0.8x | 18.3x | |
$44.2M | 0.5x | 12.5x | |
$43.8M | n/a | n/a | |
$41.2M | 2.3x | 14.4x | |
$36.9M | 0.6x | 14.9x | |
$34.8M | n/a | n/a | |
$34.6M | 1.6x | 31.3x | |
$33.8M | 9.3x | -5.1x | |
$26.9M | 2.0x | 39.2x | |
$26.8M | n/a | n/a | |
$24.2M | n/a | n/a | |
$21.5M | 2.0x | -10.0x | |
$21.0M | n/a | n/a | |
$20.7M | n/a | n/a | |
$17.9M | n/a | n/a | |
$16.5M | n/a | n/a | |
$16.3M | n/a | n/a | |
$16.3M | n/a | n/a | |
$15.8M | n/a | n/a | |
$15.0M | 1.5x | -5.0x | |
$12.9M | n/a | n/a | |
$12.4M | n/a | n/a | |
$10.2M | 2.1x | -7.6x | |
$8.9M | n/a | n/a | |
$6.4M | 39.5x | -1.9x | |
$6.1M | n/a | n/a | |
$6.0M | 116.0x | -7.8x | |
$5.5M | n/a | n/a | |
$5.4M | n/a | n/a | |
$5.3M | n/a | n/a | |
$4.1M | n/a | n/a | |
$3.7M | n/a | n/a | |
$3.6M | n/a | n/a | |
$3.3M | n/a | n/a | |
$2.6M | n/a | n/a | |
$2.4M | n/a | n/a | |
$1.9M | n/a | n/a | |
$1.9M | n/a | n/a | |
$1.7M | 4.9x | -0.1x | |
$1.6M | n/a | n/a | |
$1.1M | n/a | n/a | |
$1.0M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Chemicals